Equity Overview
Price & Market Data
Price: $0.814
Daily Change: +$0.006 / 0.74%
Range: $0.76 - $0.818
Market Cap: $62,166,796
Volume: 187,616
Performance Metrics
1 Week: 1.72%
1 Month: -6.32%
3 Months: -10.08%
6 Months: -20.00%
1 Year: -36.00%
YTD: -15.79%
Company Details
Employees: 32
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.